TickerFacts.

Profound Medical Corp. (PROF): Shareholders' Equity

Annual figures by period end, from SEC filings.

$66.43M
As of 2025-12-31
$49.81M
As of 2026-06-30
2023-12-31: $31.22M2024-12-31: $60.42M2025-12-31: $66.43M$66.43M
2023-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$66.43M+10.0%2026-03-05, Balance as of period end
2024-12-31$60.42M+93.5%2026-03-05, Balance as of period end
2023-12-31$31.22Mn/a2025-03-07, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Profound Medical Corp. (PROF)2025-12-31$66.43M+10.0%
Biotricity Inc. (BTCY)2026-03-31-$34.68Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$77.19Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$1.49Mn/m
Nephros Inc (NEPH)2025-12-31$10.20M+18.8%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$3.10M-29.8%
Spectral AI, Inc. (MDAI)2025-12-31-$5.73Mn/m
DarioHealth Corp. (DRIO)2025-12-31$67.92M-5.7%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$31.22M-21.5%

Compare PROF, BTCY, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗